Doxorubicin-induced cardiomyopathy.
Muggia
F M
FM
Speyer
J L
JL
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000517:prevention & control; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects*; D006801:Humans; D011929:Razoxane / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D002317:Cardiovascular Agents; D011929:Razoxane; D004317:Doxorubicin